Carasent Q4: Initial take - Redeye

Redeye comments on Carasent's Q4 report, which was slightly weaker than expected, partly due to issues stemming from the pandemic. However, there were several positive points as well, such as the green light for Webdoc X after a trial phase, salesforce recruitment as outbound sales showed promise, and key personnel recruitment in Norway, ready to sell Webdoc NO.

Länk till analysen i sin helhet: https://www.redeye.se/research/832469/carasent-q4-initial-take?utm_source=finwire&utm_medium=RSS